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Edited by Aleksander BenjakAbstract During the inﬂammatory response, activation of
G-protein coupled receptors (GPCRs) by inﬂammatory media-
tors rapidly leads to inhibition of gap junction intercellular com-
munication (GJIC); however, the steps that lead to this inhibition
are not known. Combining high-resolution ﬂuorescence micros-
copy and functional assays, we found that activation of the
GPCRs PAR-1 and ETA/B by their natural inﬂammatory media-
tor agonists, thrombin and endothelin-1, resulted in rapid and
acute internalization of gap junctions (GJs) that coincided with
the inhibition of GJIC followed by increased vascular permeabil-
ity. The endocytosis protein clathrin and the scaﬀold protein ZO-
1 appeared to be involved in GJ internalization, and ZO-1 was
partially displaced from GJs during the internalization process.
These ﬁndings demonstrate that GJ internalization is an eﬃcient
mechanism for modulating GJIC in inﬂammatory response.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Endothelin-1; ZO-11. Introduction
Gap junction intercellular communication (GJIC) is a fun-
damental function in nearly all tissues and plays important
roles in numerous biological processes including tissue homeo-
stasis, growth and diﬀerentiation [1,2] and embryonic develop-
ment [3]. We recently demonstrated that gap junction (GJ)
channel internalization can be achieved by at least two distinct
processes: ﬁrst, cells can rapidly internalize small double-mem-
brane annular GJ vesicles from central portions of the plaques
[4]; and second, entire GJ plaques, or large portions thereof,
can be internalized in a clathrin-mediated endocytosis-like pro-
cess [5,6]. While the ﬁrst process most likely accounts for the
continuous replenishment of functional GJ plaque channels,
we hypothesized that the latter process may be utilized under
various physiological and pathological conditions to down-Abbreviations: AGJ, annular gap junction; Cx43, connexin43; GJ, gap
junction; GJIC, gap junction intercellular communication; GPCR,
G-protein coupled receptor; PAECs, pulmonary artery endothelial
cells
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doi:10.1016/j.febslet.2008.10.043regulate GJIC and to reduce/abolish physical cell–cell con-
tacts.
Van Zeijl et al. [7] subsequently reported a rapid inhibition
of Cx43-based GJIC in response to G-protein coupled receptor
(GPCR) activation by thrombin and endothelin-1. They fur-
ther showed that PIP2 hydrolysis was both necessary and suf-
ﬁcient for GJIC inhibition, with no role for the second
messengers DAG or IP3; however, they did not investigate
how, mechanistically, inhibition was achieved. Since GJIC
inhibition was independent of second messengers that were
thought to trigger channel closure, we hypothesized that inhi-
bition of GJIC might have been achieved by the internalization
of GJ plaques. Here we report that, in primary pulmonary ar-
tery endothelial cells (PAECs), activation of the G-protein
coupled receptors (GPCRs), PAR-1 and ETA/B, by their natu-
ral inﬂammatory mediator agonists, thrombin and endothelin-
1, resulted in a rapid, acute internalization of GJs that led to
inhibition of GJIC followed by increased vascular cell perme-
ability. GJ internalization was also achieved when the recep-
tors were stimulated by the wasp toxin mastoparan, a
constitutive activator of Ga, and was eﬀectively inhibited when
G-protein activation was blocked by suramin. The endocytosis
protein clathrin and the scaﬀold protein ZO-1 appeared to be
involved in GJ internalization, and ZO-1 was partially dis-
placed from GJs during the internalization process. These ﬁnd-
ings lend direct support to our hypothesis that GJ channel
internalization is utilized to modulate GJIC under physiologi-
cal, as well as pathological conditions.2. Materials and methods
2.1. Primary vascular endothelial cell culture
Primary porcine PAECs were isolated from fresh pulmonary artery
obtained through a local slaughterhouse. Arteries were transported to
the laboratory in ice cold cord buﬀer (1.68 mM CaCl2, 2.5 mM Fe(-
NO3)3  9H2O, 25 mM glucose, 25 mM HEPES, 18.8 mM inositol,
5.4 mMKCl, 44 mMKH2PO4, 0.8 mMMgSO4  7H2O, 120 mMNaCl,
4.2 mM NaHCO3, 0.34 mM Na2HPO4 anhydrous, 1.0% Pen/Strep,
0.04% Fungizone). Endothelial cells were gently scraped oﬀ the lumenal
surface and immediately transferred to gelatin-coated tissue culture
dishes. Cells were grown at 37oC with 5% CO2 in DMEM (10.0%
FBS, 1.0% L-glutamine, 100 U/mL penicillin, 100 mg/mL streptomy-
cin). Cultures contaminatedwith smoothmuscle cells were visually iden-
tiﬁed and discarded. Endothelial cells stained positively for PECAM.2.2. HeLa-22 stable transfectant cell culture
A stable HeLa-22 cell line allowing regulation of Cx43-YFP expres-
sion was cultured as previously described [8]. Cx43-YFP expressionblished by Elsevier B.V. All rights reserved.
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to all experiments.
2.3. Immunostaining and ﬂuorescence microscopy
Immunostaining and ﬂuorescence microscopy were performed as
previously described [5]. See Supplementary materials and methods
for antibody dilutions.
2.4. Western blot analyses
See Supplemental materials and methods.
2.5. Receptor activation assays
Porcine PAECs or HeLa-22 Cx43-YFP stable transfectant cells were
grown to conﬂuence, either on poly-L-lysine-coated coverslips or on
3.5 cm tissue culture dishes. Normal growth medium was supple-
mented with thrombin (10 U/mL, Sigma), endothelin-1 (50 nM, Sig-
ma), mastoparan (240 nM, Sigma), or suramin (240 nM, Sigma) for
the indicated times prior to ﬁxation or dye transfer assays.
2.6. Scrape-loading dye transfer
Porcine PAECs were grown to conﬂuence on 3.5 cm culture dishes.
Incisions through monolayers were made in the presence of 0.05% luci-
fer yellow (Sigma). See also, Supplemental materials and methods.
2.7. Transendothelial electrical resistance (TER) measurements
Porcine PAECs were grown to conﬂuence on 12 mm polyester trans-
well ﬁlters (0.4 lm pore size) (Corning) and TER measurements were
carried out at room temperature using a Square Wave Electroporator
(model CUY21EDIT; Nepa Gene). After subtracting TER values of
empty ﬁlters, recorded values were multiplied by the ﬁlter area
(1.13 cm2) and normalized to baseline recordings of untreated cells.
Results were graphed as normalized TER ± S.E.M.
2.8. Ultrastructural analyses
Porcine PAECs were ﬁxed in 3.5% glutaraldehyde in 1· PBS for 1 h
at room temperature. Electron microscopy was performed as previ-
ously described [5].
2.9. Statistical analyses
See Supplemental materials and methods.ig. 1. Eﬀects of inﬂammatory mediator activation of GPCRs on GJ
calization. Primary porcine PAECswere treated with thrombin (10 U/
L), endothelin-1 (50 nM) or mastoparan (240 nM) for 20 min. (A)
munoﬂuorescence images (black and white inverted for better
isibility) of untreated monolayers showed numerous punctate Cx43-
ased GJs at cell peripheries (Untreated, arrowheads). Activation of
PCRs with inﬂammatory mediators, thrombin (+Thr), endothelin-1
End) or the wasp toxin, mastoparan (+Mas), resulted in loss of GJ
gnal at the PM and the appearance of numerous intracellular AGJs
rrows). (B) Ultrastructural analysis of AGJs in thrombin-treated
AECs. AGJs are visible near cell borders (upper panel) and deeper in
e cytoplasm (middle and lower panels).AGJs exhibited typical double-
embrane morphology (lower right panel, inset, arrowheads). (C)
igniﬁcant reduction of GJs at the PMwas accompanied by a signiﬁcant
crease in AGJs in thrombin-treated PAECs over time (n = 45 cells),
nd (D) after 20-min incubations with thrombin, endothelin-1 and
astoparan (n = 15 cells). Data shown are mean ± S.E.M.; P < 0.05
sterisks). MVB. multivesicular body; M, mitochondria; RER, rough
ndoplasmic reticulum.3. Results
3.1. Activation of G-protein coupled receptors by inﬂammatory
mediators stimulates GJ internalization
The thrombin PAR-1 receptor and the endothelin-1 recep-
tors, ETA and ETB, are well-characterized GPCRs ubiqui-
tously expressed by vascular endothelial cells [9,10] and it
has been reported that activation of these receptors leads to in-
creased endothelial cell permeability and down-regulation of
GJIC [11–14]. To investigate the fate of GJs in response to
activation of these receptors by their natural inﬂammatory
mediator agonists, primary porcine PAECs were exposed to
thrombin and endothelin-1, or the wasp toxin mastoparan, a
constitutive activator of Ga. In untreated PAECs expressing
endogenous Cx43, immunolabeling for Cx43 revealed the pres-
ence of numerous punctate Cx43 GJ plaques at areas of cell–
cell apposition (Fig. 1A, Untreated, arrowheads). Activation
of GPCRs with thrombin, endothelin-1 or mastoparan re-
sulted in loss of GJs at the plasma membrane within 10 min.
of treatment (Fig. 1A, +Thr, +End, +Mas). These observa-
tions were accompanied by the appearance of numerous intra-
cellular vesicles with the same intense ﬂuorescence as GJ
plaques in treated cells, both near the cell borders and cyto-
plasmically located (Fig. 1A, arrows). These we recognized
as internalized double-membrane GJ vesicles, or annular gapF
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S.M. Baker et al. / FEBS Letters 582 (2008) 4039–4046 4041junctions (AGJs), as we have characterized in previous studies
[5,6]. Ultrastructural, thin-sectioned analyses of thrombin-
treated PAECs by EM conﬁrmed the presence of vesicular
cytoplasmic structures near cell borders (Fig. 1B, upper panel,
arrows) and localized deep within the cytoplasm in the proxim-
ity of multivesicular bodies (Fig. 1B, middle left panel), mito-
chondria (Fig. 1B, middle right panel) and rough endoplasmic
reticulum (Fig. 1B, lower left panel). These Cx43-rich vesicles
exhibited the double-membrane morphology typical of inter-
nalized AGJs (Fig. 1B, lower right panel, see inset).
Statistical analysis of PAECs treated with thrombin for up
to 90 min revealed a signiﬁcant reduction of cell-surface GJs,
coupled with a signiﬁcant increase in cytoplasmic AGJs over
time (Fig. 1C). Further statistical analysis showed that when
cells were exposed to inﬂammatory mediators, thrombin and
endothelin-1, or the constitutive GPCR activator, mastoparan,
for 20 min, GJs were signiﬁcantly reduced by 95.5%, 95.7%
and virtually 100% (99.991%), respectively, when compared
to untreated PAECs (Fig. 1D). In addition, cells treated for
20 min with thrombin contain three times as many AGJs as
untreated cells; AGJs are increased more than three times
(3.3) in the presence of endothelin-1 and more than four times
(4.6) in the presence of mastoparan, all statistically signiﬁcant
increases (Fig. 1D).
3.2. GJ internalization is followed by increased vascular
endothelial cell permeability
To determine whether the observed GJ internalization re-
sulted in permeability changes in PAECs in response to inﬂam-
matory mediators, we measured transendothelial electricalFig. 2. Vascular endothelial cell permeability increases in response to
inﬂammatory mediators. (A) Phase contrast images of a single ﬁeld of
view of a PAEC monolayer pre- and post-thrombin (10 U/mL)
treatment. Note the development of smaller separations at arrows
and a larger ‘‘gap’’ (asterisk) within 30 min, as cells physically
separated from one another. (B) TER of PAECs was determined over
time before and after addition of endothelin-1 (50 nM), thrombin
(10 U/mL) or mastoparan (240 nM). Resistance measurements of
untreated cells were used to establish a baseline for normalization, and
(C) average number of GJs at the PM (n = 15 cells) and average TER
measurements (n = 9) in treated cells were compared to untreated cells
and expressed as a percentage. Values shown are means ± S.E.M.resistance (TER) for up to 90 min following activation of
GPCRs with endothelin-1, thrombin or mastoparan. Phase
contrast images of fully conﬂuent PAEC monolayers incu-
bated with thrombin for 30 min showed cells physically sepa-
rated from one another (Fig. 2A, arrows) and progressive
development of visible openings or ‘‘gaps’’ within the mono-
layer (Fig. 2A, asterisk). Without addition of agonists, TER
of fully conﬂuent PAECs remained stable throughout the 90-
min time period (Fig. 2B, Untreated). The cells demonstrated
progressive reductions in TER in response to GPCR agonists
(Fig. 2B), indicating increasing vascular cell permeability.
Overall, during 90-min incubations with endothelin-1, TER
decreased from a mean of 151 ± 4.1 X/cm2 to 10.9 ± 7.7 X/
cm2; with thrombin, TER decreased from a mean of
155.2 ± 17.5 X/cm2 to 18.1 ± 6.3 X/cm2; and with mastoparan,
TER decreased from a mean of 150.3 ± 6.3 X/cm2 to
21.1 ± 7.5 X/cm2 (see Supplemental Table S1).
When we compared the reduction in number of GJs in the
plasma membrane to reduction in TER over time, we found
that GJs were reduced by 80% ± 5.9%, while TER was reduced
by 62% ± 5.7% over the ﬁrst 10 min following GPCR activa-
tion. Over the 30–60-min time period, GJs were reduced by
96% ± 2.1% and TER was reduced by 75% ± 4.6% over the
same time course. The maximum percent reduction in TER
measured at 90 mins post-GPCR activation was 86% ± 6.8%
and maximum percent reduction in GJs was 96% ± 3.7% (Fig-
ure 2C). These results suggest that GJ internalization precedes
the observed increase in endothelial cell permeability.
3.3. GJ internalization coincides with inhibition of GJIC in
response to inﬂammatory mediators
To test the hypothesis that GJIC inhibition is achieved by
the internalization of GJ plaques in response to activation of
GPCRs, GJIC was assessed by scrape loading dye transfer as-
says using the GJ-permeable dye, lucifer yellow (LY). In un-
treated PAECs, within 5 min, dye was transferred 10–15 cells
distal to the area of the scrape (Fig. 3A). In order to establish
a basis for comparison, average ﬂuorescence intensity of LY
dye transfer was scanned along a straight line perpendicular
to the scrape in untreated cells (Fig. 3E). The area under the
curve was measured and was deﬁned as 100% dye transfer.
LY dye transfer was then assessed following GPCR activation
with endothelin-1 (Fig. 3B), thrombin (Fig. 3C) or mastoparan
(Fig. 3D) and average ﬂuorescence intensity was similarly mea-
sured (Fig. 3F–H). When dye transfer in the untreated cells was
compared to cells exposed to endothelin-1 (Fig. 3F), thrombin
(Fig. 3G) and mastoparan (Fig. 3H), dye transfer was reduced
to 0.0%, 0.7% and 0.2%, respectively, indicating rapid and eﬃ-
cient inhibition of GJIC in response to inﬂammatory media-
tors. Fig. S1A shows an average of ﬁve linescans of dye
transfer in treated and untreated cells. When compared to un-
treated cells, dye transfer, on average, was reduced to <1% fol-
lowing GPCR activation with endothelin-1 (0.14% ± 0.001),
thrombin (0.13% ± 0.001) or mastoparan (0.17% ± 0.0002).
3.4. Blocking GPCR activation prevents GJIC inhibition, GJ
internalization and increased vascular cell permeability in
the presence of inﬂammatory mediators
In order to conﬁrm that these results were due to activation
of GPCR pathways and to rule out secondary eﬀectors, we
chose to block receptor activation with suramin, a polysulfo-
nated naphthylurea which has been described as a GPCR
Fig. 3. Inhibition of GJIC coincides with GJ internalization in response to GPCR activation by inﬂammatory mediators. (A–D) GJIC was assessed
by scrape loading dye transfer in untreated PAEC monolayers (A); and following 30 min incubations with 50 nM endothelin-1 (B), 10 U/mL
thrombin (C), or 240 nM mastoparan (D). (E–H) Scans of ﬂuorescence intensity measured along lines indicated in A–D. The area under the curve for
untreated cells was set as 100% dye transfer, and the areas of the curves for treated cells were expressed as a percentage of untreated control.
4042 S.M. Baker et al. / FEBS Letters 582 (2008) 4039–4046inhibitor that both disrupts association of the Ga subunit and
prevents guanine nucleotide exchange [15,16]. We incubatedFig. 4. Eﬀects of blocking GPCR activation in the presence of inﬂammato
showed that neither GJ internalization nor cell separation occurred in PAEC
endothelin-1 (B), 10 U/mL thrombin (C), or 240 nM mastoparan (D) for 30 m
treated under the same conditions as in A–D. (I–L) Linescans of average ﬂuPAECs in serum-free medium supplemented with suramin
(240 nM) and repeated our immunoﬂuorescence and func-ry mediators. (A–D) Immunoﬂuorescence images of Cx43-based GJs
s treated with 240 nM suramin alone (A), or with suramin plus 50 nM
in. (E–H) GJIC was assessed by scrape loading dye transfer in PAECs
orescence intensity measured along the lines indicated in E–H.
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mastoparan in the presence of suramin (Fig. 4B–D), and cells
treated with suramin alone (Fig. 4A) all had numerous intact
GJ plaques at cell–cell contacts when immunolabeled for
Cx43 30 min after treatment. Moreover, when GJIC was as-
sessed using LY scrape loading dye transfer assays, GJIC
was measured at the same levels in cells treated with agonists
in the presence of suramin (Fig. 4F–H and J–L) as compared
to suramin alone (Fig. 4E and I), and quantiﬁed for ﬁve inde-
pendent linescans in Fig. S1B. These results lend direct support
to our hypothesis that GPCR activation initiates GJ channel
internalization.Fig. 5. Colocalization of Cx43 with the endocytic coat-protein clathrin
and the scaﬀold protein ZO-1. (A) Immunoﬂuorescence colocalization
showed a patchy distribution of clathrin (red) at Cx43-based GJ
plaques (green) in PAECs (Untreated, arrows; see merged inset) and
colocalized with internalized Cx43 AGJs following 20-min incubations
with 10 U/mL thrombin (+Thr, arrowheads; see merged inset). (B)
Immunoﬂuorescence colocalization showed robust colocalization of
ZO-1 (red) at virtually all Cx43-based GJ plaques (green) in untreated
PAECs (untreated, upper panel) particularly at plaque peripheries
(Untreated, lower panel, arrows; see merged inset). In PAECs treated
20 min with thrombin, ZO-1 remained localized at the PM of
separating cells (+Thr, dashed outlines), and appeared to be localized
preferentially at the center of Cx43 AGJs (+Thr, arrowheads; see
merged inset).3.5. The endocytosis coat-protein, clathrin and the scaﬀold
protein, ZO-1 are involved in the internalization of GJs
We next turned our attention to identifying the proteins in-
volved in GJ internalization in this pathway. We have previ-
ously reported a clathrin-mediated endocytosis-like process
for observed GJ internalization in cultured cells [5,6]. We thus
investigated whether clathrin may also be involved in GJ inter-
nalization in response to activation of GPCRs using immuno-
ﬂuorescence colocalization studies. A patchy distribution of
clathrin was detected at Cx43-based GJ plaques in untreated
PAECs (Fig. 5A, untreated, see inset). Following PAR-1 acti-
vation with thrombin, numerous intracellular vesicles that we
recognized as internalized AGJs according to the criteria de-
scribed above were colocalized with clathrin (Fig. 5A, +Thr,
see inset). Similar results were achieved with endothelin-1
and mastoparan (data not shown). These results support our
previous ﬁndings and suggest that GJ internalization in re-
sponse to activation of thrombin and endothelin-1 receptors
by their naturally-occurring agonists is a clathrin-mediated
process.
Since van Zeijl et al. [7] reported that ZO-1 was required for
the down-regulation of GJIC they observed in response to
thrombin and endothelin-1, we also investigated a possible role
for ZO-1 in PAECs by immunoﬂuorescence colocalization
studies. In untreated cells, ZO-1 showed robust colocalization
at virtually all Cx43-based GJ plaques and appeared to be
mainly concentrated at the plaque peripheries as well as at pla-
que-free areas of PM (Fig. 5B, untreated, see inset). Upon
stimulation with thrombin, endothelin-1 or mastoparan, ZO-
1 was displaced from internalizing plaques and remained
mostly at the plasma membranes of adjacent cells, but also ap-
peared to be localized at the center of Cx43 AGJs (Fig 5B,
+Thr, see inset).
To conﬁrm that ZO-1 is required for inﬂammatory medi-
ator-induced GJ internalization, we chose to perform a series
of experiments in HeLa-22 cells stably expressing Cx43-YFP
[8]. It has been described that Cx43 interacts with the second
PDZ domain of the ZO-1 protein via the last four amino acids
of the extreme C-terminal tail of Cx43 [17,18]. It is also known
that PDZ binding domains do not bind to internal sequences,
but rather to exposed C-terminal tails of proteins that insert
into a binding pocket formed by the PDZ domain [19]. Indeed,
tagging of the Cx43 C-terminus with myc or GFP abolishes
ZO-1 binding [17,20], presumably because such tags interfere
with binding in the pocket. Therefore, we do not expect ZO-
1 to bind Cx43-YFP in these cells.
We ﬁrst conﬁrmed that HeLa-22 stable transfectants ex-
pressed both the endothelin-1 (ET-1) receptors and the throm-bin PAR-1 receptor by Western blot (Fig. 6A). Note that
diﬀerent ET-1 receptor sub-types are expressed in diﬀerent cell
types. Immunoﬂuorescence imaging of non-permeabilized
HeLa-22 cells using antibodies directed against each of the
receptors also conﬁrmed the results obtained by Western blot
(Fig. 6B).
Colocalization of Cx43-YFP with ZO-1 was determined by
immunoﬂuorescence. Untreated HeLa-22 stable transfectant
cells contained numerous, large GJ plaques; however, ZO-1
did not colocalize with Cx43 at the plasma membrane
(Fig. 6C, untreated, see inset). When cells were treated with
thrombin, endothelin-1 or mastoparan, localization of both
Cx43-YFP and ZO-1 remained separated as in untreated cells
and no increase in GJ internalization was observed (Fig. 6C,
+Thr). As expected, due to the lack of ZO-1 binding, GJs were
larger in size than in PAECs; and thus, GJs and AGJs were
fewer in number than in PAECs. When untreated HeLa-22 sta-
ble transfectant cells were compared to those treated with
Fig. 6. ZO-1–Cx43 interaction is required for GJ internalization in response to inﬂammatory mediators. (A, B) Western blot (A) and
immunoﬂuorescence (B) of HeLa-22 cells stably expressing Cx43–YFP conﬁrmed the expression of both endothelin-1 receptors (a-ET-1 Rec) and
thrombin receptors (a-PAR-1). (C) Immunoﬂuorescence colocalization of ZO-1 (red) with Cx43-YFP (green) showed no colocalization in untreated
HeLa22 cells (untreated; see merged inset) or in HeLa22 cells treated 20 min with thrombin (+Thr; see merged inset). (D) No increase in GJ
internalization in response to thrombin, endothelin-1 or mastoparan treatment for 20 min was observed in the absence of ZO-1 binding in HeLa22
cells (n = 15 cells). Values shown are means ± S.E.M.
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tical analyses revealed no signiﬁcant changes in either number
of GJs or number of AGJs present in treated cells over time
(Fig. 6D). These results strongly suggest that ZO-1–Cx43 inter-
action is required for GJ internalization in this pathway.4. Discussion
Although the signaling pathways that control GJ internali-
zation are poorly understood, the phenomenon seems to be
widespread. Since the late 1970s, ultrastructural analyses have
identiﬁed AGJs in diverse tissue types including chick otocyst
epithelium [21], rabbit granulosa cells [22], and equine epider-
mis [23]. GJ internalization is also frequently seen in cardiovas-
cular pathologies including cardiomyopathies and cardiac
ischemic events [24–26]. In this study, we investigated the fate
of GJs in response to inﬂammatory mediators in vascular
endothelial cells. Following GPCR activation with inﬂamma-
tory mediators, primary PAECs began to internalize GJs with-
in minutes, followed by increased endothelial cell permeability
as assessed by decreased TER (Figs. 1A and 2). Upon GPCR
activation, the average number of GJ plaques at the plasma
membrane was reduced from approx. 150 to 7 (thrombin), 6
(endothelin-1) and 1 (mastoparan) within 20 min after treat-
ment. Simultaneously, the average number of cytoplasmically
localized AGJs signiﬁcantly increased from approx. 13 (in un-
treated cells) to 39, 44 and 62, respectively (Fig. 1D). While the
number of AGJs counted in treated cells was lower than theequivalent number of previously present GJ plaques, it is likely
that (I) smaller internalized plaques were excluded due to our
stringent criteria for counting AGJs and (II) that some AGJs
were already degraded at the time AGJs were counted. In addi-
tion, our functional assays conﬁrmed complete inhibition of
GJIC concomitant with the observed increase in internaliza-
tion of GJs (Fig. 3). It is important to note that our ultrastruc-
tural EM analyses showed internalized GJ vesicles that often
were localized deep within the cytoplasm (Fig. 1B, middle
and bottom panels). This would tend to rule out the possibility
that these structures are tubular invaginations of PM, since
such structures would, necessarily, be very large (>10 lm).
Moreover, tubular GJ invaginations would also be detectable
by immunoﬂuorescence and these structures were never ob-
served.
Although GJ plaques were signiﬁcantly reduced within
10 min of GPCR activation, on average, approximately six
GJ plaques per cell still remained following 20-min incubations
with thrombin and endothelin-1 (Fig. 1D). Interestingly, those
GJ channels that remained at cell contact areas were imperme-
able, as indicated by our functional dye transfer assays (Fig. 3)
suggesting that channels were closed. Given that there is some
evidence that Cx43 phosphorylation by c-Src plays a role in
regulating GJIC in response to GPCR activation [14,27], it is
plausible that channel closure via Cx phosphorylation either
precedes or occurs simultaneously with initiation of GJ inter-
nalization.
It is known that cell contractility via actomyosin cross-bridg-
ing contributes to increased vascular endothelial cell perme-
S.M. Baker et al. / FEBS Letters 582 (2008) 4039–4046 4045ability in response to inﬂammatory mediators [11,28]; how-
ever, to our knowledge, we are the ﬁrst to provide evidence
that GJs are internalized prior to cell retraction. Our data sup-
port that three events occur in sequence in PAECs in response
to GPCR activation by inﬂammatory mediators: (1) rapid
channel closure (within 1–2 min) [7]; (2) GJ internalization
(within 10–20 min) (Figs. 1A, C, D and 2C); (3) followed by
cell retraction (within 20–30 min) (Fig. 2A–C). In addition,
when receptor activation was blocked with suramin, all three
downstream events (GJIC inhibition, GJ internalization and
increased vascular permeability) were prevented (Fig. 4) indi-
cating that GPCR activation initiates the process.
Our previous studies have elucidated a mechanism for GJ
internalization that involves the clathrin-mediated endocyto-
sis machinery [5,6]. In this study, we found that, in PAECs,
clathrin colocalized with endogenous Cx43-based GJ plaques
and AGJs (Fig 5A), indicating that clathrin is involved in this
pathway as well. Ongoing studies will elucidate whether addi-
tional clathrin-mediated endocytosis proteins are also in-
volved.
It has been reported that Cx43–ZO-1 interactions regulate
GJ plaque size, and changes in Cx43–ZO-1 interactions have
been observed in diverse cell types, suggesting a role for ZO-
1 in GJ internalization.[29–32] In untreated PAECs, we ob-
served patterns of Cx43–ZO-1 colocalization that were strik-
ingly similar to those observed in cardiomyocytes by Hunter,
et al. [31] (Fig. 5B, untreated). Notably, when GJs were inter-
nalized in response to thrombin or endothelin-1, ZO-1 ap-
peared to be localized in the center of AGJ vesicles, but not
on their outer surface (Fig. 5B, +Thr; see merged inset). Re-
cently, Gilleron et al. reported a novel role for ZO-1 in GJ
internalization in response to the non-genomic carcinogen lin-
dane in 42GPA9 Sertoli cells. There, it was shown for the ﬁrst
time that ZO-1 was displaced from that side of the GJ plaque
into which the plaque was internalized, and that this mecha-
nism was c-Src dependent [33]. Our results here support a sim-
ilar pattern of ZO-1 displacement in response to inﬂammatory
mediators in PAECs and future experiments will determine
whether c-Src is involved in this pathway as well.
In contrast, in Cx43-YFP-expressing cells, GJ plaque size
was markedly increased, with no detectable Cx43–ZO-1 colo-
calization (Fig. 6C and D). These results support previous re-
ports that tagging Cx43 with ﬂuorescent proteins abolishes
ZO-1 binding and increases GJ plaque size [20]. In these cells,
no increase in GJ internalization was observed in response to
activation of GPCRs (Fig. 6D), providing further evidence
that Cx43–ZO-1 binding plays a role in this pathway. Interest-
ingly, it is known that GJ internalization can occur in the ab-
sence of ZO-1 binding, as we and others have observed [4–
6,31,34]; however, our observations here report a novel role
for ZO-1 in mediating GJ internalization in response to inﬂam-
matory mediator-induced activation of GPCRs.
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